The comparison of Staphylococcus aureus types 5 and 8 with respect to methicillin resistance in patients admitted to Al-Zahra Hospital by PCR
Seyed Asghar Havaei1, Sharareh Moghim1, Ali Mohamadi Bardebari1, Tahmineh Narimani1, Amir Azimian1, Mojtaba Akbari2
1 Department of Microbiology, School of Medicine, Isfahan, Iran
2 Isfahan University of Medical Sciences, Isfahan, Iran
|Date of Submission||12-Apr-2012|
|Date of Acceptance||21-Jul-2012|
|Date of Web Publication||06-Mar-2013|
Seyed Asghar Havaei
Department of Microbiology, Faculty of Medicine, Isfahan University of Medical Science, Hezarjerib St, Postal Code 81746 73461, Isfahan
Source of Support: None, Conflict of Interest: None
Background: Staphylococcus aureus is a common human pathogen in community- and hospital-acquired infection, and its capsule is involved in pathogenesis. The predominance of 2 capsular polysaccharides types 5 and 8, on the surface of clinical isolates, led to the development of conjugate vaccine (Staph VAX) based on capsular polysacchrides types 5 and 8 conjugated to a carrier protein.
The aim of this study was to determine the prevalence of capsular polysaccharides types 5 and 8 Staphylococcus aureus strains among isolates and their comparison with respect to methicillin resistance.
Materials and Methods: We studied the capsular genotypes of 193 isolates that encompassed both hospital- and community-acquired infection in Al-Zahra Hospital of Isfahan city from 2008 to 2009. Cap5 and 8 genes were detected by PCR method. Methicillin resistance was determined by PCR (mecA) and disk diffusion methods as well.
Result: In this population (193 cases), most of the clinical isolates (73%) expressed capsular polysaccharide type 5 (24%) and 8 (49%), whereas 27% were non-typeable. The prevalence of MRSA in type 8 was 67.9%, whereas MRSA isolates in the capsular genotype 5 were 22.2%.
Conclusion: This study Staphylococcus aureus confirms that the prevalence of capsular polysaccharide types (5 and 8) are predominant, and Staphylococcus aureus type 8 is more resistant to methicillin compared to type 5.
Keywords: Isfahan, methicillin resistance, polymerase chain reaction, Staphylococcus aureus types, types 5 and 8
|How to cite this article:|
Havaei SA, Moghim S, Bardebari AM, Narimani T, Azimian A, Akbari M. The comparison of Staphylococcus aureus types 5 and 8 with respect to methicillin resistance in patients admitted to Al-Zahra Hospital by PCR. Adv Biomed Res 2013;2:13
|How to cite this URL:|
Havaei SA, Moghim S, Bardebari AM, Narimani T, Azimian A, Akbari M. The comparison of Staphylococcus aureus types 5 and 8 with respect to methicillin resistance in patients admitted to Al-Zahra Hospital by PCR. Adv Biomed Res [serial online] 2013 [cited 2020 Feb 28];2:13. Available from: http://www.advbiores.net/text.asp?2013/2/1/13/107962
| Introduction|| |
Staphylococcus aureus is an important hospital and community bacterial pathogen.
The virulence factors of S. aureus include adhesin, cytokine, superantigens, exotoxins, enzymes and capsular polysaccharide, which are important in its pathogenicity. 
The capsule is an important virulence factor in this bacteria, which protects it from phagocytosis by scavenger cells and accounts for the higher pathogenicity in capsule-containing strains. ,
11 serotypes of S. aureus have been currently identified on the basis of capsular polysaccharide with types 5 and 8 being predominant.
Studies carried out in America and Europe indicates that S. aureus types 5 and 8 account for 70-85% of the total infections caused by this bacteria. ,,,,,
Studies also suggest that 80-90% of the isolates collected from MRSA infections in humans contain type 5 and 8 capsules. ,,
Considering the high prevalence of capsules type 5 and 8, it may serve as a suitable candidate for vaccine production.
Extensive research is currently taking place on conjugate vaccines, which are a combination of capsules type 5 and 8 with a protein. ,
The aim of this study include the following: To highlight the importance of S. aureus types 5 and 8 in producing infections, to determine the prevalence of these strains in Iran, to clarify their role in causing infections and ultimately to compare their resistance pattern against methicillin antibiotic.
| Materials and Methods|| |
In the present study, of the total 193 isolates tested, 61 isolates were from skin samples, 34 from lungs, 53 from urine, 12 from synovial and 9 isolates were of other sources.
S. aureus identification
The species were identified on the basis of colony, microscopic and morphologic characteristics and using tests including catalase, coagulase, manitol salt agar and DNase. 
S. aureus isolates were maintained on BHI agar plates for 24 hours, and DNA was extracted using phenol-chlorophorm method. 
Capsule identification by PCR
To identify capsules, type 5 and 8 PCR was carried out using the following primers:
cap5 k (5'- GTCAAAGATTATGTGATGCTACTGAG-3')
cap5 k2 (5'-ACTTCGAATATAAAC
TTGAATCAATGTTATACAG-3') for type 5 and
capsul8 k (5'-GCCTTATGTTAGGTGATAAACC-3')
capsul8 k2 (5'-GGAAAAACACTATCATAGCAGG-3') for type 8 detection.
The amount used in 30 microliter volume in each sample was as follows:
- Buffer 10 × 3 μLit, MgCl2 1.5 mM, Primer F 0.5 mM, Primer R 0.5 mM, Taq Pol 1.5 unit, dNTP Mix 0.2 mM, DNA Template 5 μLit.
Thereafter, this mixture was placed in the thermocycler for 25 cycles with the following program:
- Pre-denaturation step for 5 min at 94°C, denaturation for 30 sec at 94°C, annealing for 30 sec at 55°C, extension for 1 min at 72°C and finally post-extension for 5 min at 72°C.
- PCR products were analyzed on agarose gel 1.5 and were stained with ethidium bromide.
- The resultant fragments had a length of 361 bps for type 5 and 173 bps for type 8.
MecA detection by PCR
Following verification of S. aureus types 5 and 8, the samples were tested for MecA presence.
PCR was carried out using the following primers: 
mecA 1 F 5' TGGCTATCGTGTCACAATCG3'
mecA 2 R 5' CTGGAACTTGTTGAGCAGAG 3'
The amounts used in 50 μLit volume for each sample was the following:
Buffer 10 × 5 μLit, MgCl 2 1.5 mM, Primer F 0.5 mM, Primer R 0.5 mM, Taq Pol 2 U, dNTP Mix 0.2 mM, DNA Template 10 μLit.
Thereafter, this mixture was placed in the thermocycler for 30 cycles with the following program:
Pre-denaturation for 5 min at 94°C, denaturation for 1 min at 45°C, extension for 1 min at 72°C and finally post-extension for 7 min at 72°C.
The PCR products underwent electrophoresis on agarose gel 1%, and the resultant bands were analyzed after staining with ethidium bromide. The standard MRSA strain ATCC 33591 was used for negative and positive control for PCR test.
Sensitivity detection test by disk diffusion
Following identification of methicillin-resistant types by PCR, the resistance of these strains was tested against methicillin using disk diffusion method.
For anti-biogram tests, the samples were maintained on BHI agar plates for 24 hours, after which a microbial suspension of the same concentration with 0.5 McFarland was prepared and cultured on Muller Hinton agar medium.
Anti-biogram disks were placed on the medium after 40 min.
With respect to oxacillin, a Muller Hinton medium containing 4% Nacl and 6 μ gr oxacillin powder were used.
Thereafter, the plates were incubated for 24 hours at 37°C, and the concentration was measured. 
| Results|| |
In this study of the total 193 isolates, tested 94 (49%) were type 8, 46 (24%) type 5, and 53 (27%) were of other types.
Furthermore, 112 isolates were found to be susceptible, and 81 were resistant to methicillin. With respect to type 8, 39 isolates (41.5%) were reported susceptible and 55 isolates (58.5%) resistant to methicillin, whereas among type 5, 28 (60.9%) of the isolates were susceptible and 18 (39%) were resistant to methicillin. Among other types, 45 isolates (84.9%) were reported susceptible, and 8 (15.1%) were resistant to methicillin.
Statistically, resistance to methicillin was 67.9% for type 8 and 22.2% for type 5 and 9.9% for other types [Figure 1].
|Figure 1: Relative frequency of types (5 and 8) S. aureus in various infections|
Click here to view
In the present study, methicillin resistance was tested using PCR in 81 samples (42%) and disk diffusion in 100 samples (51.8%).
Strains tested positive by PCR were also methicillin-resistant when tested by disk diffusion [Figure 2].
|Figure 2: Gel electrophoresis of cap 5 (361 bp) and cap 8 (173 bp) gene along with negative and positive control. Lane 1: DNA ladder 50 bp. Lane 2: Distilled water. Lane 3: Positive control Renold strain (type 8). Lane 4: Distilled water. Lane 5: Positive control Becker (type 5)|
Click here to view
Although 19 isolates which were found to be methicillin-resistant by disk diffusion were negative for MecA gene [Figure 3].
|Figure 3: Gel electrophoresis of mecA gene (309 bp) along with negative and positive control. Lane 1: DNA ladder 50 bp. Lane 2: MRSA strain ATCC33591. Lane 3: Positive sample. Lane 4: MSSA strain ATCC2313. Lane 5: Distilled water|
Click here to view
With respect to disk diffusion, sensitivity and specifity was estimated 100% and 83%, respectively [Table 1].
|Table 1: Comparison of S. aureus types 5 and 8 with respect to methicillin resistance by PCR and disk diffusion methods |
Click here to view
| Discussion|| |
The aim of this study was the comparison of S. aureus types 5 and 8 with respect to methicillin resistance in patients admitted to Al-zahra hospital in Esfahan.
These isolates were collected from different infective sources, mostly skin infections (31.6%).
In this study, 73% of the isolates were either capsular type 8 (49%) or type 5 (24%) with 26% accounting for other types. The prevalence of types 5 and 8 was in accord with other studies conducted in different geographic areas. ,,,,,,
In a study carried out in 2005 by Roghamann et al. in America, a total of 259 S. aureus isolates were tested, from which capsular types 5 and 8 accounted for 50% and 42%, respectively, with 8% reported for other types. 
In another study conducted in 2007 by Verdier et al. in France, of a total 195 S. aureus isolates tested, 42% were reported to be type 5, 45% type 8 and 13% were reported for other types. 
In another study carried out in Argentina in 2009, of the total 118 S. aureus isolates collected from patients with osteomyelitis, 76 isolates (64%) were capsular types 5 and 8 where type 5 accounted for 57 isolates and type 8 accounting for 19 isolates. 
Our study reports a methicillin resistance of 67.9% in type 8, 22.2% in type 5 and 9.9% in other types. It is evident from the results that methicillin resistance was higher in type 8 compared to type 5.
In a study by Essawi et al. in 1998, of the total strains (19%) collected from patients with MRSA, 8 isolates (66.7%) were type 5. 
In a study by Na'was et al. in 1998, 65 S. aureus isolates were tested, of which, 43.1% were reported to be type 5, 44.6% type 8 and 12.3% was reported to be of other types. 9 isolates (13.8%) were found to be methicillin-resistant with 100% of the samples belonging to type 5. 
Therefore, our results were in agreement with studies such as Essawi et al, and conversely different from studies performed by Verdier, Damain, and Roghamann as they reported methicillin resistance higher in type 5. This difference is probably due to different geographic areas.
In this study of the 193 isolates tested, methicillin resistance was detected in 81 (42%) MRSA samples by PCR and in 100 (51.8%) samples by disk diffusion method.
All strains tested mecA positive using PCR were found to be methicillin-resistant by disk diffusion method.
In a study conducted by Sakoulas in 2001, of the total 203 S. aureus strains tested by phenotypy (disk diffusion) and PCR, 2 mecA positive strains were reported to be susceptible to methicillin in the disk diffusion method. 
In a study by Cekovska in 2005, a total of 210 S. aureus strains were tested for methicillin susceptibility using PCR and disk diffusion.
They reported 3 strains lacking MecA gene to be methicillin-resistant by PCR. 
In another study carried out in Turkey in 2008, 416 S. aureus strains were assessed with regards to methicillin resistance, of which 210 (51%) strains were shown to be methicillin-resistant using PCR as gold standard. In this study, 26 mecA-negative isolates were reported to be methicillin-resistant using disk diffusion method. 
In a research performed in Egypt in 2007, of the 63 clinical isolates tested, 39 isolates were found to be methicillin-resistant by PCR.
Disk diffusion was also performed, which showed of the 39 isolates found to be methicillin-resistant; by PCR, 33 (84.6%) of the isolates were resistant and 6 (15.4%) were susceptible to methicillin.
In addition, of the 24 isolates found to be methicillin susceptible by PCR, 5 isolates (20.8%) were reported methicillin-resistant when tested by disk diffusion method. 
Pseudo positive results in disk diffusion could be due to the overproduction of Beta lactamase, production of normal proteins with altered PBP binding abilities, or due to other unknown factors which can produce low levels of resistance to methicillin in S. aureus strains lacking the MecA gene. 
Furthermore, our results showed the higher prevalence of S. aureus types 5 and 8 which is similar to other countries and that over 70% of the clinical isolates contain capsules type 5 and 8.
Since the vaccine is currently passing the 3 rd phase of clinical testing and the prevalent capsules type 5 and 8 are employed in the structure of this vaccine. , This study indicates a high efficacy of the vaccine in Iran and that proves useful in over 70% of infections in high risk people.
With respect to bacterial resistance, considering the pseudopositive results in disk diffusion, PCR could be used to determine methicillin resistance.
Rapid and precise detection of methicillin-resistant strains can help in rapid onset of antibiotic therapy and the avoidance of extravagant usage of glycopeptid (as the last antibiotic of choice against methicillin-resistant strains) drugs.
| References|| |
|1.||Verdier I, Durand G, Bes M, Taylor KL, Lina G, Vandenesch F, et al. Identification of the capsular polysaccharides in Staphylococcus aureus clinical isolates by PCR and agglutination tests. J Clin Microbiol 2007;45:725-9. |
|2.||Fattom AI, Horwith G, Fuller S, Propst M, Naso R. Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: From the lab bench to phase III clinical trials. Vaccine 2004;22:880-7. |
|3.||Tzianabos AO, Wang JY, Lee JC. Structural rationale for the modulation of abscess formation by Staphylococcus aureus capsular polysaccharides. Proc Natl Acad Sci U S A 2001;98:9365-70. |
|4.||Sompolinsky D, Samra Z, Karakawa WW, Vann WF, Schneerson R, Malik Z. Encapsulation and capsular types in isolates of Staphylococcus aureus from different sources and relationship to phage types. J Clin Microbiol 1985;22:828-34. |
|5.||Cocchiaro JL, Gomez MI, Risley A, Solinga R, Sordelli DO, Lee JC. Molecular characterization of the capsule locus from non-typeable Staphylococcus aureus. Mol Microbiol 2006;59:948-60. |
|6.||von Eiff C, Taylor KL, Mellmann A, Fattom AI, Friedrich AW, Peters G, et al. Distribution of capsular and surface polysaccharide serotypes of Staphylococcus aureus. Diagn Microbiol Infect Dis 2007;58:297-302. |
|7.||Melles DC, Taylor KL, Fattom AI, van Belkum A. Serotyping of Dutch Staphylococcus aureus strains from carriage and infection. FEMS Immunol Med Microbiol 2008;52:287-92. |
|8.||Essawi T, Na'was T, Hawwari A, Wadi S, Doudin A, Fattom AI. Molecular, antibiogram and serological typing of Staphylococcus aureus isolates recovered from Al-Makased Hospital in East Jerusalem. Trop Med Int Health 1998;3:576-83. |
|9.||Na'was T, Hawwari A, Hendrix E, Hebden J, Edelman R, Martin M, et al. Phenotypic and genotypic characterization of nosocomial Staphylococcus aureus isolates from trauma patients. J Clin Microbiol 1998;36:414-20. |
|10.||Sutter DE, Summers AM, Keys CE, Taylor KL, Frasch CE, Braun LE, et al. Capsular serotype of Staphylococcus aureus in the era of community-acquired MRSA. FEMS Immunol Med Microbiol 2011;63:16-24. |
|11.||Branger C, Goullet P, Boutonnier A, Fournier JM. Correlation between esterase electrophoretic types and capsular polysaccharide types 5 and 8 among methicillin-susceptible and methicillin-resistant strains of Staphylococcus aureus. J Clin Microbiol 1990;28:150-1. |
|12.||Roghmann M, Taylor KL, Gupte A, Zhan M, Johnson JA, Cross A, et al. Epidemiology of capsular and surface polysaccharide in Staphylococcus aureus infections complicated by bacteraemia. J Hosp Infect 2005;59:27-32. |
|13.||Shinefield H, Black S, Fattom A, Horwith G, Rasgon S, Ordonez J, et al. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med 2002;346:491-6. |
|14.||Forbes BA, Sahm DF, Weissfeld AS. Bailey and Scott's Diagnostic Microbiology. 12 th ed. USA: Elsevier; 2007. p. 172-213. |
|15.||Kumar R, Yadav BR, Dev K, Singh RS. A simple protocol for DNA extraction from Staphylococcus aureus. Protocol Online 2008. Available from: http://www.protocol-online.org/prot/Protocols/A-Simple-Protocol-for-DNA-Extraction-from-Staphylococcus-Aureus-4999.html [Last accessed on 18.01.2012]. |
|16.||Baddour MM, AbuElKheir MM, Fatani AJ. Comparison of mecA polymerase chain reaction with phenotypic methods for the detection of methicillin-resistant Staphylococcus aureus. Curr Microbiol 2007;55:473-9. |
|17.||Lattar SM, Tuchscherr LP, Caccuri RL, Centrón D, Becker K, Alonso CA, et al. Capsule expression and genotypic among Staphylococcus aureus isolates from patients with chronic or acute osteomyelitis. Infect Immun 2009;77:1968-75. |
|18.||Sakoulas G, Gold HS, Venkataraman L, DeGirolami PC, Eliopoulos GM, Qian Q. Methicillin-resistant Staphylococcus aureus: comparison of susceptibility testing methods and analysis of mecA-positive susceptible strains. J Clin Microbiol 2001;39:3946-51. |
|19.||Cekovska Z, Panovski N, Petrovska M. Methicillin-resistant Staphylococcus aureus: comparison of susceptibility test methods with mecA gene analysis for determining oxacillin (methicillin) resistance in our clinical isolates. Bratisl Lek Listy 2005;106:163-7. |
|20.||Adaleti R, Nakipoglu Y, Karahan ZC, Tasdemir C, Kaya F. Comparison of polymerase chain reaction and conventional methods in detecting methicillin-resistant Staphylococcus aureus. J Infect Dev Ctries 2008;2:46-50. |
[Figure 1], [Figure 2], [Figure 3]